Prognostic value of plasma Epstein–Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy

BACKGROUND: The value of Epstein–Barr virus (EBV) DNA assay during posttreatment follow-up of the patients with nasopharyngeal carcinoma (NPC) presenting with different pretreatment plasma EBV DNA levels remains unclear. In the present study, we aimed to evaluate the prognostic value of plasma EBV D...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wen-Fei, Zhang, Yuan, Huang, Xiao-Bin, Du, Xiao-Jing, Tang, Ling-Long, Chen, Lei, Peng, Hao, Guo, Rui, Sun, Ying, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678814/
https://www.ncbi.nlm.nih.gov/pubmed/29116021
http://dx.doi.org/10.1186/s40880-017-0256-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678814/
https://www.ncbi.nlm.nih.gov/pubmed/29116021
http://dx.doi.org/10.1186/s40880-017-0256-x

Ejemplares similares